Post-approval studies (Phase 4)Study completedNCT02642653
What this trial is testing
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
Who this might be right for
Fragile X SyndromeGenetic Diseases
University of California, Davis 30